Matches in Wikidata for { <http://www.wikidata.org/entity/Q89932066> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- Q89932066 description "article scientifique publié en 2020" @default.
- Q89932066 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q89932066 description "im Februar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89932066 description "scientific article published on 27 February 2020" @default.
- Q89932066 description "wetenschappelijk artikel" @default.
- Q89932066 description "наукова стаття, опублікована 27 лютого 2020" @default.
- Q89932066 name "Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial" @default.
- Q89932066 name "Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial" @default.
- Q89932066 type Item @default.
- Q89932066 label "Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial" @default.
- Q89932066 label "Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial" @default.
- Q89932066 prefLabel "Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial" @default.
- Q89932066 prefLabel "Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial" @default.
- Q89932066 P1433 Q89932066-81B9ED21-6ECA-40A2-B385-122C3F00D621 @default.
- Q89932066 P1476 Q89932066-09A76FCE-F56B-4459-A179-8D0380BBD713 @default.
- Q89932066 P2093 Q89932066-46D18118-6C2D-4495-8D80-86C9E135D3A0 @default.
- Q89932066 P2093 Q89932066-542CDBFC-0BC8-4E8B-8510-729E393B859C @default.
- Q89932066 P2093 Q89932066-5A404530-062C-4B29-BD57-74807FB05944 @default.
- Q89932066 P2093 Q89932066-638D406B-5C28-4A36-962C-0B9BC96CB911 @default.
- Q89932066 P2093 Q89932066-6C60A3F2-A53D-4D87-B313-A9D083BA3CB3 @default.
- Q89932066 P2093 Q89932066-87719C2E-2318-4F89-89E1-05FACEDECD0F @default.
- Q89932066 P2093 Q89932066-884BC735-FF15-4D11-85C0-2199D61FAC13 @default.
- Q89932066 P2093 Q89932066-91353A99-E3E4-43BD-B505-029A0A4BD152 @default.
- Q89932066 P2093 Q89932066-B1B35AB4-831F-4034-8C39-217B322C314C @default.
- Q89932066 P2093 Q89932066-FC7AA650-B535-4147-9930-445B7E2F9D67 @default.
- Q89932066 P2860 Q89932066-15569E1B-D1A8-4F20-9284-2612E7DBD3A0 @default.
- Q89932066 P2860 Q89932066-1C72B87D-693F-411C-929E-9A6988920DA5 @default.
- Q89932066 P2860 Q89932066-4B9B51EF-D5FF-4950-9D2D-89073C65CFF9 @default.
- Q89932066 P2860 Q89932066-535CBD51-AEA6-4FBF-A1D0-FD618F529373 @default.
- Q89932066 P2860 Q89932066-81684655-C8DF-4E6C-99AD-3383E6CCBAE2 @default.
- Q89932066 P2860 Q89932066-8723F229-15B1-4DE5-BF3A-3782F3E83D1A @default.
- Q89932066 P2860 Q89932066-88AF06C3-12A8-43BB-A746-58112677A6B2 @default.
- Q89932066 P2860 Q89932066-903936AF-9229-48BF-A87A-2C2937471E0D @default.
- Q89932066 P2860 Q89932066-A5795A82-2A17-490C-8E8D-D9DDD31D68D7 @default.
- Q89932066 P2860 Q89932066-FF374F67-7F89-4688-BFAE-15DAB37A8AFE @default.
- Q89932066 P31 Q89932066-31132DDD-FA72-4971-A142-60D2D91778FC @default.
- Q89932066 P356 Q89932066-6D494146-C187-4F8D-872C-BB6289731927 @default.
- Q89932066 P50 Q89932066-E1204B03-A8CD-4C8D-8913-20BF58D89662 @default.
- Q89932066 P577 Q89932066-E5ABCECA-A067-4757-A738-D5B621F481B9 @default.
- Q89932066 P698 Q89932066-A102C0F4-A283-476A-AE62-CFF4D15AE369 @default.
- Q89932066 P921 Q89932066-2C923BF4-9753-4076-A39B-1F617101B20E @default.
- Q89932066 P921 Q89932066-ACCA3667-7F65-4F82-90AD-339CF7D06F8D @default.
- Q89932066 P921 Q89932066-CEFD46E8-6FCE-4CCD-9A2E-D48BB5B037F6 @default.
- Q89932066 P356 PMRJ.12348 @default.
- Q89932066 P698 32108436 @default.
- Q89932066 P1433 Q15816818 @default.
- Q89932066 P1476 "Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial" @default.
- Q89932066 P2093 "Allison Brashear" @default.
- Q89932066 P2093 "Anne-Sophie Grandoulier" @default.
- Q89932066 P2093 "Claire Vilain" @default.
- Q89932066 P2093 "Francois Constant-Boyer" @default.
- Q89932066 P2093 "Gaëtan Stoquart" @default.
- Q89932066 P2093 "Jean-Michel Gracies" @default.
- Q89932066 P2093 "Luis Jorge Jacinto" @default.
- Q89932066 P2093 "Peter Hedera" @default.
- Q89932066 P2093 "Philippe Picaut" @default.
- Q89932066 P2093 "Ugo Dimanico" @default.
- Q89932066 P2860 Q28074221 @default.
- Q89932066 P2860 Q35901849 @default.
- Q89932066 P2860 Q35997976 @default.
- Q89932066 P2860 Q38046142 @default.
- Q89932066 P2860 Q38559645 @default.
- Q89932066 P2860 Q44623049 @default.
- Q89932066 P2860 Q47107133 @default.
- Q89932066 P2860 Q47951336 @default.
- Q89932066 P2860 Q83365098 @default.
- Q89932066 P2860 Q83860821 @default.
- Q89932066 P31 Q13442814 @default.
- Q89932066 P356 "10.1002/PMRJ.12348" @default.
- Q89932066 P50 Q89932064 @default.
- Q89932066 P577 "2020-02-27T00:00:00Z" @default.
- Q89932066 P698 "32108436" @default.
- Q89932066 P921 Q117060 @default.
- Q89932066 P921 Q2291130 @default.
- Q89932066 P921 Q4095199 @default.